Healthcare News and Headlines
Healthcare News and Headlines
Mankind Pharma used World Kidney Day to spotlight the escalating burden of chronic kidney disease (CKD) in India, where an estimated 138 million people are affected—far above the global average of 10 percent. The campaign highlighted the disease’s silent progression, noting that up to 90 percent of kidney function can be lost before symptoms appear, making routine screening essential. It also underscored a stark transplant gap: India needs roughly 200,000 kidneys annually but performs only about 13,500 transplants, less than 6 percent of demand. By urging regular monitoring of blood pressure, blood sugar and kidney function, the initiative aims to drive early detection and preventive lifestyle changes.
The FDA has granted approval for leucovorin, a folinic‑acid formulation, to treat a rare metabolic disorder despite the absence of new clinical trial data. The decision leans on decades of off‑label use and historical safety records rather than prospective studies....
WVU Medicine announced expansion of Abridge’s ambient AI platform to over 2,800 clinicians across its 25‑hospital network. The rollout, driven by clinician advocacy, aims to alleviate physician burnout in rural West Virginia. Post‑implementation surveys of more than 200 providers reported...
The NHS Confederation’s report highlights that fragmented dental referrals are a core barrier to sustainable NHS dentistry. Digital referral optimisation, as demonstrated by NEC Rego, standardises forms, embeds clinical guidance and delivers real‑time data to Integrated Care Systems. Early pilots in...
The Supreme Court is set to decide Chiles v. Salazar, a case challenging Colorado's ban on conversion therapy for minors. The dispute centers on whether talk‑based treatments aimed at changing sexual orientation or gender identity constitute protected speech or regulated...
Life Biosciences has secured FDA IND approval for ER-100, the first partial epigenetic reprogramming therapy to enter human trials. The gene‑therapy delivers OCT‑4, SOX‑2 and KLF‑4 to retinal ganglion cells via a single intravitreal injection, aiming to reset age‑related epigenetic...
The National Council on Compensation Insurance reports that opioid costs in workers’ compensation fell an average 2.8% annually from 2012 to 2023, dropping median claim expenses from $188 to $105. Meanwhile, topical medication spend rose from $38 to $62 per...
A burr hole drill is a specialized neurosurgical instrument that creates a small, precise opening in the skull to grant controlled access for a range of procedures. Modern designs feature high torque and automatic disengagement once the bone is penetrated,...
Astellas Pharma leveraged the Trump administration’s push for lower U.S. drug prices to argue for higher reimbursement for its eye drug Izervay in Japan, winning a more generous price level. Meanwhile, a review of FDA adverse event reports found that...
Coloplast announced that former Johnson & Johnson executive Gavin Wood will assume the role of chief executive officer on May 1, ending a ten‑month search for a permanent leader. Wood arrives after serving as J&J’s group chairman for MedTech across Europe,...
Equatorial Guinea has launched a $116 million Vision 2030 malaria elimination strategy, building on two decades of success on Bioko Island where prevalence fell to 7.2 % in 2025. The programme aims to eradicate malaria nationwide, improve public‑health outcomes and remove a key...
The FDA is rolling out the Adverse Event Monitoring System (AEMS), replacing the legacy FAERS platform and consolidating reporting across drugs, biologics, devices, cosmetics, food, tobacco, and veterinary products. AEMS introduces standardized electronic submissions, AI‑driven redaction and analytics, and a...
CharmHealth has introduced CharmCopilot, an embedded multi‑agent AI assistant built directly into its electronic health record platform. The company is offering the core AI capabilities to existing customers at no additional charge, positioning the tool as a cost‑disruptive solution. Its...
The FDA is launching the Adverse Event Monitoring System (AEMS) to replace the legacy FAERS platform and bring together reporting for drugs, vaccines, devices, food, cosmetics, tobacco, and veterinary products. AEMS introduces standardized reporting protocols, AI‑driven redaction and digitization, and...
Healthcare organizations must prioritize staff safety to achieve clinical excellence. Research shows physical and psychological safety are top predictors of patient safety grades, and a 10% rise in staff turnover intent correlates with a 14% increase in inpatient mortality. Burnout...
Researchers at ETH Zurich have introduced a boron‑based ligation strategy that overcomes the concentration barrier in chemical protein synthesis. By masking potassium acyltrifluoroborates (KATs) with chiral zwitterionic complexes, the team achieved efficient peptide coupling at micromolar levels, far lower than...
Stamford Health, a 305‑bed independent system in Connecticut, has chosen Ensemble Health Partners to run its end‑to‑end revenue cycle management. Ensemble will apply its integrated operating model, AI‑driven analytics, and existing EHR infrastructure to automate billing, coding and denial recovery....
Imprivata unveiled Agentic Identity Management at HIMSS26, a platform that secures and governs AI agents used in clinical documentation, prior authorizations, and triage. The solution treats AI agents as managed identities, issuing short‑lived tokens and enforcing least‑privilege access across both...
A recent early‑access study published in npj Science of Food reports that oral matcha consumption reduced sneezing in mice engineered to exhibit allergic rhinitis. The mice received matcha tea two to three times weekly for over five weeks and a...
The letter challenges the claim that adult ADHD is overdiagnosed, arguing that the DSM‑5’s broader criteria simply correct a historic underdiagnosis. It highlights that clinicians often lack the training and time needed for comprehensive neuropsychological assessments, leading to diagnostic shortcuts....
At HIMSS26, Sequoia Project’s Didi Davis unveiled the second USCDI v3 data‑usability guide, expanding coverage to all data classes and emphasizing provenance, traceability, and persistent identifiers. The 60‑page guide outlines use cases across provider‑to‑provider, provider‑to‑public‑health, and provider‑to‑consumer exchanges, aiming to curb...
Researchers published in JAMA Neurology identified high‑level EBNA‑1 peptide antibody titers as a robust biomarker that distinguishes relapsing‑remitting multiple sclerosis from MOGAD and seronegative NMOSD. In a cohort of over 1,300 neuroinflammatory patients, persistent EBNA‑1 positivity in at least two...
University of Queensland and University of Minnesota researchers identified distinct ATP patterns in the brains and blood cells of young adults with major depressive disorder. The study found that resting cells produce higher ATP levels but cannot increase energy output...
UCB announced results from its Phase III BE BOLD trial comparing Bimzelx (bimekizumab) to risankizumab in 553 adults with active psoriatic arthritis. The study met its primary endpoint, showing Bimzelx superior in achieving ACR50 responses at week 16. Bimzelx is...
Krishna Institute of Medical Sciences (KIMS) Hospitals received board approval to raise up to ₹1,500 crore through a Qualified Institutional Placement (QIP). The capital may be issued in one or more tranches, with the Finance and Investment Committee setting the final...
Employers are turning to diagnostic‑first centers of excellence, such as the Mayo Clinic Complex Care Program, to address costly, undiagnosed conditions among high‑spending employees. By consolidating multidisciplinary evaluations into days rather than months, the model has generated average Year‑1 savings...
An international team led by the Turku Bioscience Centre discovered that applying sound‑wave vibration to vocal‑fold cancer cells restores cellular movement and markedly reduces tumor aggressiveness. The mechanical stimulation lowered levels of the oncogenic protein YAP, both in cultured cells...
Oncology is moving toward combination regimens, and Merck's Keytruda paired with Pfizer/Astellas' Padcev has emerged as a leading duo. A phase 3 trial in muscle‑invasive bladder cancer showed the combo cut the risk of recurrence, progression and death roughly in half,...
An emulated target trial using the TriNetX database compared tocilizumab and rituximab in 1,194 rheumatoid arthritis‑associated interstitial lung disease (RA‑ILD) patients each over a five‑year follow‑up. The analysis found no statistically significant difference in all‑cause mortality (15.9% vs 17.7%) or...
Capricor Therapeutics announced that the FDA has scheduled an August 22 decision on its investigational Duchenne muscular dystrophy cell therapy, deramiocel, after lifting a prior complete response letter. The biotech resubmitted an enhanced package that includes robust Phase III HOPE‑3 data showing...
The American Academy of Allergy, Asthma & Immunology presented the first allergy and immunology workforce survey since 1998, revealing that 41.7% of clinicians report burnout while most remain satisfied with their careers. Demographically, women now represent 39% of the specialty,...
ARTHEx Biotech announced that its RNA‑based drug ATX‑01 has received U.S. FDA Fast Track designation for treating Myotonic Dystrophy Type 1 (DM1). The therapy works by inhibiting miR‑23b, thereby increasing free MBNL protein, correcting splicing errors and reducing toxic DMPK mRNA...
UK health agencies and the Wellcome charity have launched a joint initiative to fund high‑quality infectious‑disease clinical trials in Africa, South Asia and Southeast Asia. The program, co‑led by the NIHR, the Foreign Commonwealth Development Office and Wellcome, will prioritize...
Validic unveiled a new integration with Salesforce Health Cloud at HIMSS, linking remote patient monitoring and wearable data to the platform's 360-degree patient view. The partnership delivers HIPAA‑compliant, real‑time device data alongside EHR information, enabling health systems, payers, and life‑science...
RA Capital, Forbion, and Canaan have collectively invested in Solstice Therapeutics, the CTLA-4 antibody partner of Harbour Therapeutics. The funding round, reportedly a multi‑million dollar Series B, will support Solstice's pre‑clinical and early clinical programs. By backing Solstice, the investors...
Early data presented at the San Antonio Breast Cancer Symposium indicate that GLP‑1 receptor agonists, long used for diabetes and obesity, are linked to markedly lower breast cancer recurrence and mortality. Retrospective analyses of thousands of patients showed up to...
The FDA issued a high‑risk safety alert for Erbe USA’s flexible cryoprobes used in interventional radiology. The devices can rupture during activation because of insufficient adhesive, producing loud sounds that may cause tinnitus, temporary or permanent hearing loss, and burns....
LucidHealth announced it will rename its teleradiology services division to Lucid Teleradiology, aiming to boost brand visibility and clarify its service offering. The change coincides with appointing Dr. David West as practice president, reinforcing physician leadership. The division currently employs...
Swiss biotech Idorsia has signed an exclusive agreement with UAE‑based Pharmalink Drug Store to distribute its insomnia drug Quviviq (daridorexant) across Kuwait, Oman, Qatar, Bahrain and the United Arab Emirates. Under the deal Idorsia will receive an upfront payment, retain...
NICE has issued final draft guidance recommending fezolinetant 45 mg once daily for moderate to severe menopause‑related vasomotor symptoms when hormone replacement therapy is unsuitable. The recommendation enables the drug to be supplied through the NHS, providing a new non‑hormonal option...
Researchers at Oregon State University have developed a DNA‑based barcoding assay that measures, in living mice, which lipid nanoparticles successfully deliver gene‑editing cargo to target cellular compartments. The technique identified that many particles are degraded in lysosomes, while a newly...
Researchers at Brown University, Rhode Island Hospital, and VA Providence demonstrated that simultaneous electrical stimulation above and below a spinal cord lesion can restore both leg movement and spatial sensory feedback in people with complete spinal cord injuries. In a...
A new study published in Nature Medicine shows that a single course of antibiotics can alter the gut microbiome for up to eight years. Researchers linked Sweden’s national drug‑dispensing register with microbiome data from 14,979 adults, revealing lasting changes in...
A new Swedish study of nearly 15,000 adults linked a single course of antibiotics to lasting reductions in gut microbial diversity, with effects persisting up to eight years. Clindamycin was the most disruptive, eliminating an average of 47 bacterial species...
Digital Health Rewired returns to the NEC in Birmingham on March 24‑25, 2026, featuring a dedicated Health Innovation Network zone where eight AI‑focused innovators will showcase solutions for cancer, mental health, and missed appointments. The agenda includes the EMAP session...
The Department for Health and Social Care announced a major expansion of dentist registration capacity, adding up to 2,400 overseas‑trained dentists each year from 2028‑29. The plan also boosts the Licence in Dental Surgery exam from 180 to 1,800 places...
An employee enrolled in a $1,000 health care flexible spending account (FSA) discovered that unused funds can be lost unless the plan offers a grace period or rollover. The author learned that his plan provides a $660 rollover but no...
QT Imaging has secured FDA 510(k) clearance for an updated Breast Acoustic CT scanner, a 3‑D ultrasound tomographic system designed to improve visualization of posterior breast tissue. The new configuration features a tilted transmitter geometry that expands coverage near the...
Canada‑based Kainova Therapeutics announced positive top‑line results from its Phase I EPRAD study of DT‑9081, an oral EP4 receptor antagonist, in patients with advanced, recurrent and metastatic solid tumours. The trial, conducted at four sites in Belgium and France, met all...
Mount Sinai Health System has signed a system‑wide contract with Clear Secure to deploy facial‑recognition scanners across its seven hospitals and roughly 400 outpatient clinics, serving about five million patient visits annually. The technology, already used in airports and major...
